Centessa Pharmaceuticals plc Quarterly Interest Expense in USD from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Centessa Pharmaceuticals plc quarterly/annual Interest Expense history and growth rate from Q1 2022 to Q1 2024.
  • Centessa Pharmaceuticals plc Interest Expense for the quarter ending March 31, 2024 was $2.53M, a 7.85% increase year-over-year.
  • Centessa Pharmaceuticals plc Interest Expense for the twelve months ending March 31, 2024 was $10.1M, a 24.2% increase year-over-year.
  • Centessa Pharmaceuticals plc annual Interest Expense for 2023 was $9.91M, a 36.1% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $10.1M $2.53M +$184K +7.85% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $9.91M $2.57M +$368K +16.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $9.54M $2.54M +$619K +32.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $8.92M $2.45M +$797K +48.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $8.12M $2.35M +$845K +56.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $7.28M $2.2M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1.92M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $1.65M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $1.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.